Insider · CIK 0001230724

GUGGENHIME ANDREW

Reports to the SEC for 7 companies · SAN CARLOS, CA

sec.gov

Transactions

Companies

Filings

CIK

0001230724

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-08	PCVXVaxcyte, Inc.F Tax Payment	PRESIDENT AND CFO	FTax Payment	−7,155 sh	$60.36	−$432K	95,316
2026-09-02	PCVXVaxcyte, Inc.F Tax Payment	PRESIDENT AND CFO	FTax Payment	−1,432 sh	$61.58	−$88.2K	102,471
2026-08-31	PCVXVaxcyte, Inc.F Tax Payment	PRESIDENT AND CFO	FTax Payment	−1,273 sh	$60.74	−$77.3K	103,903
2026-08-03	PCVXVaxcyte, Inc. · Stock Option (right to buy)M Exercise/Conversion	PRESIDENT AND CFO	MExercise/Conversion	−10K sh	—	—	216,827
2026-08-03	PCVXVaxcyte, Inc.M Exercise/Conversion	PRESIDENT AND CFO	MExercise/Conversion	+10K sh	$5.35	+$53.5K	115,176
2026-08-03	PCVXVaxcyte, Inc.S Sale	PRESIDENT AND CFO	SSale	−3,044 sh	$54.18	−$165K	105,176
2026-08-03	PCVXVaxcyte, Inc.S Sale	PRESIDENT AND CFO	SSale	−6,956 sh	$53.76	−$374K	108,220
2026-07-06	PCVXVaxcyte, Inc.S Sale	PRESIDENT AND CFO	SSale	−7,913 sh	$57.16	−$452K	106,482
2026-07-06	PCVXVaxcyte, Inc.S Sale	PRESIDENT AND CFO	SSale	−2,087 sh	$57.76	−$121K	104,395
2026-07-06	PCVXVaxcyte, Inc.M Exercise/Conversion	PRESIDENT AND CFO	MExercise/Conversion	+10K sh	$5.35	+$53.5K	114,395
2026-07-06	PCVXVaxcyte, Inc. · Stock Option (right to buy)M Exercise/Conversion	PRESIDENT AND CFO	MExercise/Conversion	−10K sh	—	—	226,827
2026-06-18	PCVXVaxcyte, Inc. · Stock Option (right to buy)M Exercise/Conversion	PRESIDENT AND CFO	MExercise/Conversion	−10K sh	—	—	236,827
2026-06-18	PCVXVaxcyte, Inc.S Sale	PRESIDENT AND CFO	SSale	−10K sh	$53.00	−$530K	104,395
2026-06-18	PCVXVaxcyte, Inc.M Exercise/Conversion	PRESIDENT AND CFO	MExercise/Conversion	+10K sh	$5.35	+$53.5K	114,395
2026-03-09	PCVXVaxcyte, Inc.F Tax Payment	PRESIDENT AND CFO	FTax Payment	−1,021 sh	$59.32	−$60.6K	104,395
2026-03-02	PCVXVaxcyte, Inc.F Tax Payment	PRESIDENT AND CFO	FTax Payment	−1,009 sh	$61.98	−$62.5K	105,416
2026-02-28	PCVXVaxcyte, Inc.F Tax Payment	PRESIDENT AND CFO	FTax Payment	−898 sh	$61.98	−$55.7K	106,425
2026-02-26	PCVXVaxcyte, Inc.A Award	PRESIDENT AND CFO	AAward	+44.9K sh	—	—	107,323
2026-02-26	PCVXVaxcyte, Inc. · Stock Option (right to buy)A Award	PRESIDENT AND CFO	AAward	+75K sh	—	—	74,993
2026-02-20	CRBUCaribou Biosciences, Inc. · Option to purchase Common StockA Award	Director	AAward	+45K sh	—	—	45,000
2026-01-14	PCVXVaxcyte, Inc.G Gift	PRESIDENT AND CFO	GGift	+61.9K sh	—	—	61,850
2026-01-14	PCVXVaxcyte, Inc.G Gift	PRESIDENT AND CFO	GGift	−61.9K sh	—	—	62,459
2025-09-08	PCVXVaxcyte, Inc.F Tax Payment	PRESIDENT AND CFO	FTax Payment	−2,890 sh	$32.41	−$93.7K	124,309
2025-09-02	PCVXVaxcyte, Inc.F Tax Payment	PRESIDENT AND CFO	FTax Payment	−1,270 sh	$31.56	−$40.1K	131,009
2025-09-02	PCVXVaxcyte, Inc.F Tax Payment	PRESIDENT AND CFO	FTax Payment	−2,381 sh	$31.56	−$75.1K	128,628
2025-09-02	PCVXVaxcyte, Inc.F Tax Payment	PRESIDENT AND CFO	FTax Payment	−1,429 sh	$31.56	−$45.1K	127,199
2025-04-07	PCVXVaxcyte, Inc.M Exercise/Conversion	PRESIDENT AND CFO	MExercise/Conversion	+4,777 sh	$20.93	+$100K	131,950
2025-04-07	PCVXVaxcyte, Inc. · Stock Option (right to buy)M Exercise/Conversion	PRESIDENT AND CFO	MExercise/Conversion	−4,777 sh	—	—	121,115
2025-03-03	PCVXVaxcyte, Inc.F Tax Payment	PRESIDENT AND CFO	FTax Payment	−3,809 sh	$72.10	−$275K	127,173
2025-02-28	PCVXVaxcyte, Inc.F Tax Payment	PRESIDENT AND CFO	FTax Payment	−1,270 sh	$73.02	−$92.7K	130,982
2025-02-27	PCVXVaxcyte, Inc. · Stock Option (right to buy)A Award	PRESIDENT AND CFO	AAward	+76K sh	—	—	75,991
2025-02-27	PCVXVaxcyte, Inc.A Award	PRESIDENT AND CFO	AAward	+22.8K sh	—	—	132,252
2025-02-20	CRBUCaribou Biosciences, Inc. · Option to purchase Common StockA Award	Director	AAward	+40.5K sh	—	—	40,500
2025-02-18	PCVXVaxcyte, Inc.S Sale	PRESIDENT AND CFO	SSale	−6,182 sh	$83.64	−$517K	111,309
2025-02-18	PCVXVaxcyte, Inc.M Exercise/Conversion	PRESIDENT AND CFO	MExercise/Conversion	+8,000 sh	$5.35	+$42.8K	117,491
2025-02-18	PCVXVaxcyte, Inc.S Sale	PRESIDENT AND CFO	SSale	−1,818 sh	$84.58	−$154K	109,491
2025-02-18	PCVXVaxcyte, Inc. · Stock Option (right to buy)M Exercise/Conversion	PRESIDENT AND CFO	MExercise/Conversion	−8,000 sh	—	—	246,827
2025-01-21	PCVXVaxcyte, Inc. · Stock Option (right to buy)M Exercise/Conversion	PRESIDENT AND CFO	MExercise/Conversion	−8,000 sh	—	—	254,827
2025-01-21	PCVXVaxcyte, Inc.M Exercise/Conversion	PRESIDENT AND CFO	MExercise/Conversion	+8,000 sh	$5.35	+$42.8K	117,491
2025-01-21	PCVXVaxcyte, Inc.S Sale	PRESIDENT AND CFO	SSale	−5,318 sh	$86.08	−$458K	112,173
2025-01-21	PCVXVaxcyte, Inc.S Sale	PRESIDENT AND CFO	SSale	−1,999 sh	$87.25	−$174K	110,174
2025-01-21	PCVXVaxcyte, Inc.S Sale	PRESIDENT AND CFO	SSale	−683 sh	$87.70	−$59.9K	109,491
2024-12-18	PCVXVaxcyte, Inc.S Sale	PRESIDENT AND CFO	SSale	−280 sh	$90.24	−$25.3K	109,491
2024-12-18	PCVXVaxcyte, Inc.S Sale	PRESIDENT AND CFO	SSale	−3,157 sh	$89.31	−$282K	109,771
2024-12-18	PCVXVaxcyte, Inc.S Sale	PRESIDENT AND CFO	SSale	−3,373 sh	$88.70	−$299K	112,928
2024-12-18	PCVXVaxcyte, Inc.S Sale	PRESIDENT AND CFO	SSale	−1,190 sh	$87.26	−$104K	116,301
2024-12-18	PCVXVaxcyte, Inc.M Exercise/Conversion	PRESIDENT AND CFO	MExercise/Conversion	+8,000 sh	$5.35	+$42.8K	117,491
2024-12-18	PCVXVaxcyte, Inc. · Stock Option (right to buy)M Exercise/Conversion	PRESIDENT AND CFO	MExercise/Conversion	−8,000 sh	—	—	262,827
2024-11-18	PCVXVaxcyte, Inc. · Stock Option (right to buy)M Exercise/Conversion	PRESIDENT AND CFO	MExercise/Conversion	−8,000 sh	—	—	270,827
2024-11-18	PCVXVaxcyte, Inc.S Sale	PRESIDENT AND CFO	SSale	−132 sh	$87.05	−$11.5K	109,491

Recent filings

Accepted (ET)
Sep 94
GUGGENHIME ANDREW0001230724-26-000018
SEC(opens sec.gov)
Sep 24
GUGGENHIME ANDREW0001230724-26-000016
SEC(opens sec.gov)
Aug 54
GUGGENHIME ANDREW0001230724-26-000014
SEC(opens sec.gov)
Jul 64
GUGGENHIME ANDREW0001230724-26-000012
SEC(opens sec.gov)
Jun 184
GUGGENHIME ANDREW0001230724-26-000010
SEC(opens sec.gov)
Mar 114
GUGGENHIME ANDREW0001230724-26-000008
SEC(opens sec.gov)
Mar 24
GUGGENHIME ANDREW0001230724-26-000006
SEC(opens sec.gov)
Feb 204
GUGGENHIME ANDREW0001230724-26-000004
SEC(opens sec.gov)

Companies

Address

C/O VAXCYTE, INC. 825 INDUSTRIAL ROAD, STE. 300

SAN CARLOS, CA, 94070